These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 16225752)

  • 1. CPU 86017, p-chlorobenzyltetrahydroberberine chloride, attenuates monocrotaline-induced pulmonary hypertension by suppressing endothelin pathway.
    Zhang TT; Cui B; Dai DZ; Su W
    Acta Pharmacol Sin; 2005 Nov; 26(11):1309-16. PubMed ID: 16225752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering.
    Mawatari E; Hongo M; Sakai A; Terasawa F; Takahashi M; Yazaki Y; Kinoshita O; Ikeda U
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):594-600. PubMed ID: 17581214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CPU0213, a non-selective ETA/ETB receptor antagonist, improves pulmonary arteriolar remodeling of monocrotaline-induced pulmonary hypertension in rats.
    Cui B; Cheng YS; Dai DZ; Li N; Zhang TT; Dai Y
    Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):169-75. PubMed ID: 18986320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
    Homma N; Morio Y; Takahashi H; Yamamoto A; Suzuki T; Sato K; Muramatsu M; Fukuchi Y
    Respiration; 2006; 73(1):105-12. PubMed ID: 16432296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of nitric oxide and endothelin-1 in monocrotaline-induced pulmonary hypertension in rats.
    Mathew R; Zeballos GA; Tun H; Gewitz MH
    Cardiovasc Res; 1995 Nov; 30(5):739-46. PubMed ID: 8595621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific inhibition of p38 mitogen-activated protein kinase with FR167653 attenuates vascular proliferation in monocrotaline-induced pulmonary hypertension in rats.
    Lu J; Shimpo H; Shimamoto A; Chong AJ; Hampton CR; Spring DJ; Yada M; Takao M; Onoda K; Yada I; Pohlman TH; Verrier ED
    J Thorac Cardiovasc Surg; 2004 Dec; 128(6):850-9. PubMed ID: 15573069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease.
    Zhao YD; Courtman DW; Deng Y; Kugathasan L; Zhang Q; Stewart DJ
    Circ Res; 2005 Mar; 96(4):442-50. PubMed ID: 15692087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CPU0213, a novel endothelin receptor antagonist, ameliorates septic renal lesion by suppressing ET system and NF-kappaB in rats.
    He HB; Dai DZ; Dai Y
    Acta Pharmacol Sin; 2006 Sep; 27(9):1213-21. PubMed ID: 16923343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sildenafil limits monocrotaline-induced pulmonary hypertension in rats through suppression of pulmonary vascular remodeling.
    Yen CH; Leu S; Lin YC; Kao YH; Chang LT; Chua S; Fu M; Wu CJ; Sun CK; Yip HK
    J Cardiovasc Pharmacol; 2010 Jun; 55(6):574-84. PubMed ID: 20224427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of endogenous sulfur dioxide on monocrotaline-induced pulmonary hypertension in rats.
    Jin HF; Du SX; Zhao X; Wei HL; Wang YF; Liang YF; Tang CS; Du JB
    Acta Pharmacol Sin; 2008 Oct; 29(10):1157-66. PubMed ID: 18817619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of endothelium-derived hyperpolarizing factor is augmented in monocrotaline-induced pulmonary hypertension of rat lungs.
    Morio Y; Homma N; Takahashi H; Yamamoto A; Nagaoka T; Sato K; Muramatsu M; Fukuchi Y
    J Vasc Res; 2007; 44(4):325-35. PubMed ID: 17438361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous transplantation of bone marrow-derived endothelial progenitor cells attenuates monocrotaline-induced pulmonary arterial hypertension in rats.
    Yip HK; Chang LT; Sun CK; Sheu JJ; Chiang CH; Youssef AA; Lee FY; Wu CJ; Fu M
    Crit Care Med; 2008 Mar; 36(3):873-80. PubMed ID: 18431275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of monocrotaline-induced pulmonary arterial hypertension in rats by rosuvastatin.
    Li XL; Guan RJ; Li JJ
    J Cardiovasc Pharmacol; 2012 Aug; 60(2):219-26. PubMed ID: 22592772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
    Liu CP; Dai ZK; Huang CH; Yeh JL; Wu BN; Wu JR; Chen IJ
    Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-arginine restores endothelial nitric oxide synthase-coupled activity and attenuates monocrotaline-induced pulmonary artery hypertension in rats.
    Ou ZJ; Wei W; Huang DD; Luo W; Luo D; Wang ZP; Zhang X; Ou JS
    Am J Physiol Endocrinol Metab; 2010 Jun; 298(6):E1131-9. PubMed ID: 20215577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in gene expressions encoding preproET-1 and NOS in pulmonary tissue in endotoxemic rats.
    Zaedi S; Jesmin S; Maeda S; Shimojo N; Yamaguchi I; Goto K; Miyauchi T
    Exp Biol Med (Maywood); 2006 Jun; 231(6):992-6. PubMed ID: 16741036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. m-Nisoldipine attenuates monocrotaline-induced pulmonary hypertension by suppressing 5-HT/ERK MAPK pathway.
    Chen XY; Zhang W; Miao QF; Zhang YJ
    Yao Xue Xue Bao; 2008 Oct; 43(10):1011-8. PubMed ID: 19127864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of debanding on the lung expression of ET-1, eNOS, and cGMP in rats with left ventricular pressure overload.
    Chou SH; Chai CY; Wu JR; Tan MS; Chiu CC; Chen IJ; Jeng AY; Chang CI; Kwan AL; Dai ZK
    Exp Biol Med (Maywood); 2006 Jun; 231(6):954-9. PubMed ID: 16741030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of rosuvastatin on monocrotaline-induced pulmonary artery hypertension in rats].
    Li XL; Guan RJ; Xu QH; Wu ZY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Mar; 39(3):247-53. PubMed ID: 21609531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KMUP-1 ameliorates monocrotaline-induced pulmonary arterial hypertension through the modulation of Ca2+ sensitization and K+-channel.
    Dai ZK; Cheng YJ; Chung HH; Wu JR; Chen IJ; Wu BN
    Life Sci; 2010 May; 86(19-20):747-55. PubMed ID: 20303989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.